BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 37445604)

  • 1. Gender Influences Gut Microbiota among Patients with Irritable Bowel Syndrome.
    Pecyna P; Gabryel M; Mankowska-Wierzbicka D; Nowak-Malczewska DM; Jaskiewicz K; Jaworska MM; Tomczak H; Rydzanicz M; Ploski R; Grzymislawski M; Dobrowolska A; Gajecka M
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations of Gut Microbiota in Patients With Irritable Bowel Syndrome Based on 16S rRNA-Targeted Sequencing: A Systematic Review.
    Duan R; Zhu S; Wang B; Duan L
    Clin Transl Gastroenterol; 2019 Feb; 10(2):e00012. PubMed ID: 30829919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut microbial signatures of patients with diarrhea-predominant irritable bowel syndrome and their healthy relatives.
    Chen J; Lan H; Li C; Xie Y; Cheng X; Xia R; Ke C; Liang X
    J Appl Microbiol; 2024 Jun; 135(6):. PubMed ID: 38849305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical response to fecal microbiota transplantation in patients with diarrhea-predominant irritable bowel syndrome is associated with normalization of fecal microbiota composition and short-chain fatty acid levels.
    Mazzawi T; Hausken T; Hov JR; Valeur J; Sangnes DA; El-Salhy M; Gilja OH; Hatlebakk JG; Lied GA
    Scand J Gastroenterol; 2019 Jun; 54(6):690-699. PubMed ID: 31190584
    [No Abstract]   [Full Text] [Related]  

  • 5. Gut Bacterial Dysbiosis in Irritable Bowel Syndrome: a Case-Control Study and a Cross-Cohort Analysis Using Publicly Available Data Sets.
    Kim GH; Lee K; Shim JO
    Microbiol Spectr; 2023 Feb; 11(1):e0212522. PubMed ID: 36652592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternation of the gut microbiota in irritable bowel syndrome: an integrated analysis based on multicenter amplicon sequencing data.
    Chen H; Ou R; Tang N; Su W; Yang R; Yu X; Zhang G; Jiao J; Zhou X
    J Transl Med; 2023 Feb; 21(1):117. PubMed ID: 36774467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristic dysbiosis of gut microbiota of Chinese patients with diarrhea-predominant irritable bowel syndrome by an insight into the pan-microbiome.
    Wang Z; Xu CM; Liu YX; Wang XQ; Zhang L; Li M; Zhu SW; Xie ZJ; Wang PH; Duan LP; Zhu HQ
    Chin Med J (Engl); 2019 Apr; 132(8):889-904. PubMed ID: 30958430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significant Differences in Gut Microbiota Between Irritable Bowel Syndrome with Diarrhea and Healthy Controls in Southwest China.
    Yao C; Li Y; Luo L; Xie F; Xiong Q; Li T; Yang C; Feng PM
    Dig Dis Sci; 2023 Jan; 68(1):106-127. PubMed ID: 35503487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stool and urine trefoil factor 3 levels: associations with symptoms, intestinal permeability, and microbial diversity in irritable bowel syndrome.
    Heitkemper MM; Cain KC; Shulman RJ; Burr RL; Ko C; Hollister EB; Callen N; Zia J; Han CJ; Jarrett ME
    Benef Microbes; 2018 Apr; 9(3):345-355. PubMed ID: 29633639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut fungal dysbiosis and altered bacterial-fungal interaction in patients with diarrhea-predominant irritable bowel syndrome: An explorative study.
    Hong G; Li Y; Yang M; Li G; Qian W; Xiong H; Bai T; Song J; Zhang L; Hou X
    Neurogastroenterol Motil; 2020 Nov; 32(11):e13891. PubMed ID: 32449259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diarrhoea-predominant irritable bowel syndrome distinguishable by 16S rRNA gene phylotype quantification.
    Lyra A; Rinttilä T; Nikkilä J; Krogius-Kurikka L; Kajander K; Malinen E; Mättö J; Mäkelä L; Palva A
    World J Gastroenterol; 2009 Dec; 15(47):5936-45. PubMed ID: 20014457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut microbiome signatures reflect different subtypes of irritable bowel syndrome.
    Su Q; Tun HM; Liu Q; Yeoh YK; Mak JWY; Chan FK; Ng SC
    Gut Microbes; 2023; 15(1):2157697. PubMed ID: 36573834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in gut microbial composition correlate with regional brain volumes in irritable bowel syndrome.
    Labus JS; Hollister EB; Jacobs J; Kirbach K; Oezguen N; Gupta A; Acosta J; Luna RA; Aagaard K; Versalovic J; Savidge T; Hsiao E; Tillisch K; Mayer EA
    Microbiome; 2017 May; 5(1):49. PubMed ID: 28457228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compositional and Functional Changes in the Gut Microbiota in Irritable Bowel Syndrome Patients.
    Lee SM; Kim N; Yoon H; Kim YS; Choi SI; Park JH; Lee DH
    Gut Liver; 2021 Mar; 15(2):253-261. PubMed ID: 32457278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A starch- and sucrose-reduced dietary intervention in irritable bowel syndrome patients produced a shift in gut microbiota composition along with changes in phylum, genus, and amplicon sequence variant abundances, without affecting the micro-RNA levels.
    Nilholm C; Manoharan L; Roth B; D'Amato M; Ohlsson B
    United European Gastroenterol J; 2022 May; 10(4):363-375. PubMed ID: 35484927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut microbiota composition and functional prediction in diarrhea-predominant irritable bowel syndrome.
    Mei L; Zhou J; Su Y; Mao K; Wu J; Zhu C; He L; Cui Y
    BMC Gastroenterol; 2021 Mar; 21(1):105. PubMed ID: 33663411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The gut microbiota participates in the effect of linaclotide in patients with irritable bowel syndrome with constipation (IBS-C): a multicenter, prospective, pre-post study.
    Zhou J; Wei H; Zhou A; Xiao X; Xie X; Tang B; Lin H; Tang L; Meng R; Yuan X; Zhang J; Huang C; Huang B; Liao X; Zhong T; He S; Gu S; Yang S
    J Transl Med; 2024 Jan; 22(1):98. PubMed ID: 38263117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for an association of gut microbial Clostridia with brain functional connectivity and gastrointestinal sensorimotor function in patients with irritable bowel syndrome, based on tripartite network analysis.
    Labus JS; Osadchiy V; Hsiao EY; Tap J; Derrien M; Gupta A; Tillisch K; Le Nevé B; Grinsvall C; Ljungberg M; Öhman L; Törnblom H; Simren M; Mayer EA
    Microbiome; 2019 Mar; 7(1):45. PubMed ID: 30898151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinctions Between Fecal and Intestinal Mucosal Microbiota in Subgroups of Irritable Bowel Syndrome.
    Hou Y; Dong L; Lu X; Shi H; Xu B; Zhong W; Ma L; Wang S; Yang C; He X; Zhao Y; Wang S
    Dig Dis Sci; 2022 Dec; 67(12):5580-5592. PubMed ID: 35879512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Gut Microbiota and Metabolites Signature in Patients With Irritable Bowel Syndrome.
    Zhu S; Liu S; Li H; Zhang Z; Zhang Q; Chen L; Zhao Y; Chen Y; Gu J; Min L; Zhang S
    Front Cell Infect Microbiol; 2019; 9():346. PubMed ID: 31681624
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.